EUVIMEDEUVIMED entdecken
Crossref

Extracellular vesicle miRNA detection based on membrane fusion and nucleic acid nanostructures

Jixuan Han, Xiaoran Liu, Ying Yan, Jingwen Ge, Han Zhao, Chen Wang, Guohong Song, Ling Zhu, Yanlian Yang

Biosensors and Bioelectronics · 2025

DOI: 10.1016/j.bios.2025.117763 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Jixuan Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Standardization and Measurement for Nanotechnology, National Center for Nanoscience and Technology, Beijing, 100190, China; Sin…. Hauptthemen laut MEDLINE: Extracellular Vesicles, MicroRNAs, Biosensing Techniques, Breast Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicle miRNAs (EV-miRNAs) are strongly linked to cancer progression, metastasis, and drug resistance, making them promising biomarkers for precision diagnosis. However, the clinical potential of EV-miRNA-based liquid biopsies is hindered by the low abundance of EV-miRNAs and the tedious detection procedure including EV separation, purification and miRNA quantification. Here, we develop a novel one-step catalytic hairpin assembly (CHA)-based fluorescent assay for sensitive detection of EV-miRNAs assisted with DNA-mediated membrane fusion (DMF) and DNA tetrahedron (DT) (DMF-DT-CHA). This DMF-DT-CHA assay facilitates the membrane fusion between liposome and EV through interactions between DNAs for DT-CHA probe delivery into EVs, and followed by DT-CHA, which recognizes target miRNAs to initiate non-enzymatic signal amplification via CHA-based fluorescence emission. We analyzed EVs from three breast cancer cell sources using DMF-DT-CHA and the results were consistent with qPCR and the platform achieved the limit of detection (LoD) of 0.24 fM for EV-miRNAs. We performed a clinical evaluation of the DMF-DT-CHA assay platform. Recipient operating characteristic curves (ROCs) showed that the DMF-DT-CHA platform was an excellent classifier for distinguishing breast cancer (BC) patients from healthy donors and breast cancer patients from benign breast nodule patients, with area under the curve (AUC) values of 0.850 and 0.835, respectively, as well as an accuracy of 81.1 % in response to treatment for triple-negative breast cancer. DMF-CT-CHA assay platform has clinical potential for cancer diagnosis and treatment monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesMicroRNAsBiosensing TechniquesBreast NeoplasmsNanostructuresHumansFemaleMembrane FusionLimit of DetectionDNALiposomesCell Line, TumorBiomarkers, Tumor

Stichwörter der Autor:innen

CancerExtracellular vesicleMembrane fusionNucleic acid probeSignal amplificationmiRNA

Substanzen

MicroRNAsDNALiposomesBiomarkers, Tumor

Autor:innen und Institutionen

  • CAS Key Laboratory of Standardization and Measurement for Nanotechnology, National Center for Nanoscience and Technology, Beijing, 100190, China; Sino-Danish College, University of Chinese Academy of Sciences, Beijing,…
  • Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • CAS Key Laboratory of Standardization and Measurement for Nanotechnology, National Center for Nanoscience and Technology, Beijing, 100190, China.
  • Sino-Danish College, University of Chinese Academy of Sciences, Beijing, 101408, China; Sino-Danish Centre for Education and Research, Beijing, 101408, China. Electronic address: wangch@nanoctr.cn.
  • Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China. Electronic address: songguohong91…

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Han, J., Liu, X., Yan, Y., Ge, J., Zhao, H., Wang, C., Song, G., Zhu, L., & Yang, Y. (2025). Extracellular vesicle miRNA detection based on membrane fusion and nucleic acid nanostructures. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.117763

Vancouver

Han J, Liu X, Yan Y, Ge J, Zhao H, Wang C, et al. Extracellular vesicle miRNA detection based on membrane fusion and nucleic acid nanostructures. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2025.117763

BibTeX
@article{Han2025,
  author = {Han, Jixuan and Liu, Xiaoran and Yan, Ying and Ge, Jingwen and Zhao, Han and Wang, Chen and Song, Guohong and Zhu, Ling and Yang, Yanlian},
  title = {Extracellular vesicle miRNA detection based on membrane fusion and nucleic acid nanostructures},
  journal = {Biosensors and Bioelectronics},
  year = {2025},
  doi = {10.1016/j.bios.2025.117763}
}
Kostenlos starten →